Cargando…

Cost-effectiveness of scaling up short course preventive therapy for tuberculosis among children across 12 countries

BACKGROUND: While household contact investigation is widely recommended as a means to reduce the burden of tuberculosis (TB) among children, only 27% of eligible pediatric household contacts globally received preventive treatment in 2018. We assessed the cost-effectiveness of household contact inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jo, Youngji, Gomes, Isabella, Flack, Joseph, Salazar-Austin, Nicole, Churchyard, Gavin, Chaisson, Richard E., Dowdy, David W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846666/ https://www.ncbi.nlm.nih.gov/pubmed/33554088 http://dx.doi.org/10.1016/j.eclinm.2020.100707

Ejemplares similares

Cost‐effectiveness of a 12 country‐intervention to scale up short course TB preventive therapy among people living with HIV
por: Shin, Hyejeong, et al.
Publicado: (2020)

Cost‐effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in Uganda
por: Ferguson, Olivia, et al.
Publicado: (2020)

Impact and cost-effectiveness of short-course tuberculosis preventive treatment for household contacts and people with HIV in 29 high-incidence countries: a modelling analysis
por: Ryckman, Theresa, et al.
Publicado: (2023)

Costs and cost-effectiveness of a comprehensive tuberculosis case finding strategy in Zambia
por: Jo, Youngji, et al.
Publicado: (2021)

Cost-Effectiveness of Automated Digital Microscopy for Diagnosis of Active Tuberculosis
por: Jha, Swati, et al.
Publicado: (2016)

Sub-district level correlation between tuberculosis notifications and socio-demographic factors in Dhaka City corporation, Bangladesh
por: Jo, Youngji, et al.
Publicado: (2021)

Controlling latent TB tuberculosis infection in high-burden countries: A neglected strategy to end TB
por: Churchyard, Gavin J., et al.
Publicado: (2019)

Costing the implementation of public health interventions in resource-limited settings: a conceptual framework
por: Sohn, Hojoon, et al.
Publicado: (2020)

Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug-resistant tuberculosis in South Africa
por: Shah, Maunank, et al.
Publicado: (2013)

What We Know About Tuberculosis Transmission: An Overview
por: Churchyard, Gavin, et al.
Publicado: (2017)

Impact and Cost-Effectiveness of Culture for Diagnosis of Tuberculosis in HIV-Infected Brazilian Adults
por: Dowdy, David W., et al.
Publicado: (2008)

Comparative assessment of the cost-effectiveness of Tuberculosis (TB) active case-finding interventions: A systematic analysis of TB REACH wave 5 projects
por: Gomes, Isabella, et al.
Publicado: (2022)

Yield of household contact tracing for tuberculosis in rural South Africa
por: Little, Kristen M., et al.
Publicado: (2018)

Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis
por: Foster, Nicola, et al.
Publicado: (2021)

Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries
por: Schluger, Neil, et al.
Publicado: (2007)

Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries
por: Campbell, Jonathon R., et al.
Publicado: (2019)

Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation
por: Vassall, Anna, et al.
Publicado: (2017)

Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugees
por: Ilaiwy, Ghassan, et al.
Publicado: (2021)

Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We’re There?
por: Auld, Sara C, et al.
Publicado: (2017)

Pragmatic cluster-randomized trial of home-based preventive treatment for TB in Ethiopia and South Africa (CHIP-TB)
por: Malhotra, Akash, et al.
Publicado: (2023)

Trends in tuberculosis clinicians’ adoption of short-course regimens for latent tuberculosis infection
por: Feng, Pei-Jean I., et al.
Publicado: (2023)

Indirect Costs of Inflammatory Bowel Diseases: A Comparison of Patient-Reported Outcomes Across 12 European Countries
por: Holko, Przemysław, et al.
Publicado: (2022)

Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in India
por: Little, Kristen M., et al.
Publicado: (2015)

Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
por: Moodley, Riya, et al.
Publicado: (2016)

Population-Level Impact of Shorter-Course Regimens for Tuberculosis: A Model-Based Analysis
por: Fofana, Mariam O., et al.
Publicado: (2014)

Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis
por: Thompson, Ryan R, et al.
Publicado: (2023)

Empiric tuberculosis treatment in South African primary health care facilities - for whom, where, when and why: Implications for the development of tuberculosis diagnostic tests
por: McCarthy, Kerrigan, et al.
Publicado: (2018)

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model
por: Kendall, Emily A., et al.
Publicado: (2017)

Short-Term Outcomes and Cost-Effectiveness between Long-Course Chemoradiation and Short-Course Radiotherapy for Locally Advanced Rectal Cancer
por: Cho, Min Soo, et al.
Publicado: (2023)

Serological Testing Versus Other Strategies for Diagnosis of Active Tuberculosis in India: A Cost-Effectiveness Analysis
por: Dowdy, David W., et al.
Publicado: (2011)

Clinical and genomic responses to ultra-short course chemotherapy in spinal tuberculosis
por: Niu, Ningkui, et al.
Publicado: (2017)

Short-Course Regimen for Multidrug-Resistant Tuberculosis: A Decade of Evidence
por: Trébucq, Arnaud, et al.
Publicado: (2019)

Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries
por: Norhammar, Anna, et al.
Publicado: (2022)

Pre- and post-diagnosis costs of tuberculosis to patients on Directly Observed Treatment Short course in districts of southwestern Ethiopia: a longitudinal study
por: Asres, Abyot, et al.
Publicado: (2018)

A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis
por: Dowdy, David W, et al.
Publicado: (2014)

Development of a Scientific Writing Course to Increase Fellow Scholarship
por: Moore, Amy L., et al.
Publicado: (2022)

A Model-Based Cost-Effectiveness Analysis of Long-Acting Monoclonal Antibody (Tixagevimab and Cilgavimab: Evusheld) Preventive Treatment for High-Risk Populations Against SARS-CoV-2 in Korea
por: Jo, Youngji, et al.
Publicado: (2023)

Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence
por: Currie, Christine SM, et al.
Publicado: (2005)

High Tuberculosis Prevalence in a South African Prison: The Need for Routine Tuberculosis Screening
por: Telisinghe, Lilanganee, et al.
Publicado: (2014)

Cost-effectiveness of Short-Course Radiation Therapy vs Long-Course Chemoradiation for Locally Advanced Rectal Cancer
por: Raldow, Ann C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bg298fcu172cqen0rb8lqvvct2